Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria.
about
Cerebral malaria: mysteries at the blood-brain barrierPlasmodium yoelii 17XL infection up-regulates RANTES, CCR1, CCR3 and CCR5 expression, and induces ultrastructural changes in the cerebellumSpecific depletion of Ly6C(hi) inflammatory monocytes prevents immunopathology in experimental cerebral malariaPerivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral MalariaReal-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesisHistamine H(3) receptor-mediated signaling protects mice from cerebral malaria.Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity.CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria.Species-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp.Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection.IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malariaCD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature.The role of chemokines in severe malaria: more than meets the eye.Pathogenic CD8+ T cells in experimental cerebral malaria.Cytokines and Chemokines in Cerebral Malaria Pathogenesis.The role of chemokines and their receptors during protist parasite infections.Do we know enough to find an adjunctive therapy for cerebral malaria in African children?Flt3 ligand treatment modulates parasitemia during infection with rodent malaria parasites via MyD88- and IFN-γ-dependent mechanisms.
P2860
Q21032533-2855BF94-C14D-4E68-82C5-FBE6D3C9164CQ25256830-B3400593-A878-4717-B1DC-EA820FE74540Q27309244-59836F7E-F0A5-4446-9D69-401777DA2FC4Q27316972-425D1F62-4AD2-4DA1-9C3B-713EDCE0862FQ27324676-9F246105-96DE-4A51-A1AE-6BD7C56A549BQ33472679-6EE012C7-67A4-4F99-8519-C2A42F9632D7Q33685904-C0EC5923-6DC0-4783-8DBC-5A27E8781204Q33873437-470AD766-0D1B-45C3-8DCC-647C704DD0E4Q33946786-06035EF3-9F64-49B3-847B-15A3C6E4CD0FQ34706971-CC0B94FB-6CB7-475F-88B7-43ADE1019F5AQ35187600-3753AC57-C3D2-4D3C-B798-A3186554FBC4Q36210506-63284379-9CD5-4AD9-A31B-F9C3D5524E3DQ37655274-529F3929-3176-4E5E-BEAF-6D6023FB4BA5Q38378859-5961FCBB-35D5-4B17-B6A9-11E2BD3470BFQ40107124-FA05A390-F0EA-4A99-A236-68A8807E1FEFQ40515876-BB4677BB-0DCE-4BDF-A16C-17757669C88FQ46237821-790548F4-7108-4D76-81A5-75E61CB12ABAQ47850518-A50DBE70-7532-4A7C-BCF0-33563014B91F
P2860
Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Chemokine receptor CCR2 is not ...... experimental cerebral malaria.
@ast
Chemokine receptor CCR2 is not ...... experimental cerebral malaria.
@en
type
label
Chemokine receptor CCR2 is not ...... experimental cerebral malaria.
@ast
Chemokine receptor CCR2 is not ...... experimental cerebral malaria.
@en
prefLabel
Chemokine receptor CCR2 is not ...... experimental cerebral malaria.
@ast
Chemokine receptor CCR2 is not ...... experimental cerebral malaria.
@en
P2093
P2860
P1476
Chemokine receptor CCR2 is not ...... experimental cerebral malaria.
@en
P2093
Elodie Belnoue
Fabio T M Costa
Françoise Gonnet
Irène Landau
Matthias Mack
Nico Van Rooijen
Tatiana Voza
William A Kuziel
P2860
P304
P356
10.1128/IAI.71.6.3648-3651.2003
P407
P577
2003-06-01T00:00:00Z